Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

In each pair, one patient had received Jardiance, a pill from a class of drugs known as SGLT2 inhibitors, and the other received a DPP4 inhibitor such as Merck’s (MRK.N), opens new tab Januvia ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

In August, CMS announced discounts on 10 popular drugs like Enbrel, Jardiance and Januvia, starting in 2026. In Q4 2024, Medicare Part B patients could save up to $3,000 on key cancer medications ...

However, uptake of these medications has been slow ... SGLT-2 inhibitors include empagliflozin (Jardiance) and dapagliflozin (Farxiga), and GLP-1 agonists include semaglutide (Ozempic) and ...